MAGL inhibitors
Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL. Furthermore, the subject compounds and compositions are useful for the treatment of pain.
1. A compound:
or a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 :
3. A compound:
or a pharmaceutically acceptable salt thereof.
4. The compound of claim 3 :
5. A compound:
or a pharmaceutically acceptable salt thereof.
6. The compound of claim 5 :
7. A compound:
or a pharmaceutically acceptable salt thereof.
8. The compound of claim 7 :
9. A compound:
or a pharmaceutically acceptable salt thereof.
10. The compound of claim 9 :
11. A compound:
or a pharmaceutically acceptable salt thereof.
12. The compound of claim 11 :
13. A compound:
or a pharmaceutically acceptable salt thereof.
14. The compound of claim 13 :
15. A compound:
or a pharmaceutically acceptable salt thereof.
16. The compound of claim 15 :